Prakt. Lékáren. 2019; 15(3e): 15-27
Progress in developing new monoclonal antibodies allows us to affect pathological immune processes on many different levels. For treatment
of different diseases, we now have available monoclonal antibodies. Also, the development of new humanized and human antibodies caused
significant improvement of their safety profile. This article briefly summarizes the antibodies used in non-oncological indications.
Published: October 10, 2019 Show citation